Skip to main content

Latest ACR News

      Dr. Jack Cush presents his favorite abstracts and presentations from Rheumatology Round Up and ACR 2019.
      Making Better Posters: Dr. David Liew
      Dr. David Liew describes how some presenters are working to make their posters better design-wise to improve their presentation at the 2019 ACR/ARP annual meeting in Atlanta.
      RT @_connectedcare: Hand OA responds to 10mg/d Pred over 6wks. As expected symptoms return on cessationAnecdotally, there are people who…

      Dr Irwin Lim _connectedcare

      5 years ago

      Hand OA responds to 10mg/d Pred over 6wks. As expected symptoms return on cessation Anecdotally, there are people who do well on pragmatic, long term low dose eg 5mg or less/d #ACR19 @rheumnow Abst1760 https://t.co/FtE9vHb655

      #ACR19 Rheumatology RoundUp - Kavanaughs Picks:
      2505 PsA prevention
      1366 Self Joint exams
      1120 Rheum burnout
      1310 OA Hx
      565 Enteropathic arthritis Re

      Dr. John Cush RheumNow

      5 years ago
      #ACR19 Rheumatology RoundUp - Kavanaughs Picks: 2505 PsA prevention 1366 Self Joint exams 1120 Rheum burnout 1310 OA Hx 565 Enteropathic arthritis Recs 1823 MRE dx of SI 2773 Machine learning 2772 Antiinflammatory diet in RA 1359 Synovial Bx
      #ACR19 Rheumatology RoundUp - Cushs Abstract Picks:
      1223 ALLN-346 Urate Degrading Enzyme
      L06 Emapalumab in MAS
      1890 2357 MTX Safety
      1240 anaGO
      22

      Dr. John Cush RheumNow

      5 years ago
      #ACR19 Rheumatology RoundUp - Cushs Abstract Picks: 1223 ALLN-346 Urate Degrading Enzyme L06 Emapalumab in MAS 1890 2357 MTX Safety 1240 anaGO 2292 2279 Biologic WD in Preg 633 631 AS Delays in Dx & referral 196 VTE & ASCVD 2566 Polypharmacy in SLE
      RT @hausmannMD: CAPS is caused by mutations in NLRP3, a component of the inflammasome.It is thought that NLRP3 mutations lead to the unc…

      Jonathan Hausmann MD hausmannMD

      5 years ago

      CAPS is caused by mutations in NLRP3, a component of the inflammasome. It is thought that NLRP3 mutations lead to the uncontrolled production of the inflammatory cytokine IL-1b.

      RT @hausmannMD: Patients with more severe #CAPS phenotypes may develop hearing loss, amyloidosis, aseptic meningitis, intellectual impairme…

      Jonathan Hausmann MD hausmannMD

      5 years ago
      Patients with more severe #CAPS phenotypes may develop hearing loss, amyloidosis, aseptic meningitis, intellectual impairment, or #arthritis.
      RT @hausmannMD: Holy Molly! TNFi (etanercept, adalimumab, infliximab, or golimumab) completely prevented stokes in patients with DADA2. #AC…

      Jonathan Hausmann MD hausmannMD

      5 years ago
      Holy Molly! TNFi (etanercept, adalimumab, infliximab, or golimumab) completely prevented stokes in patients with DADA2. #ACR19 @RheumNow
      RT @hausmannMD: "I usually do not" give methotrexate to men with RA who are trying to conceive. Dr. Bathon.

      "But methotrexate is in serum…

      Jonathan Hausmann MD hausmannMD

      5 years ago
      "I usually do not" give methotrexate to men with RA who are trying to conceive. Dr. Bathon. "But methotrexate is in serum for brief periods, unlikely to affect semen, unlikely to affect pregnancy." Dr. Bykerk #ACR19 @RheumNow
      RT @hausmannMD: However, 15-30% of patients with acute pericarditis develop recurrent pericarditis

      Jonathan Hausmann MD hausmannMD

      5 years ago
      However, 15-30% of patients with acute pericarditis develop recurrent pericarditis
      RT @hausmannMD: Recurrent pericarditis (RP) is the recurrence of pericarditis after a more than 4-6 week symptom-free period.

      RP is typica…

      Jonathan Hausmann MD hausmannMD

      5 years ago
      Recurrent pericarditis (RP) is the recurrence of pericarditis after a more than 4-6 week symptom-free period. RP is typically treated with steroids, colchicine, NSAIDs. Nevertheless, RP is associated with a high burden of disease and there is an unmet need for better treatment.
      RT @synovialjoints: The highlight of the last day of #ACR19 is the Rheumatology Roundup Highlights #ACRBest by Drs. John Cush @RheumNow and…

      Dr. Antoni Chan synovialjoints

      5 years ago

      The highlight of the last day of #ACR19 is the Rheumatology Roundup Highlights #ACRBest by Drs. John Cush @RheumNow and Arthur Kavanaugh @ACRheum always worth attending with great take home messages #rheum https://t.co/eMdvc2byKG

      ×